Oncova Therapeutics Inc. (ONTX) plunged in the premarket; here’s why
In the premarket, ONTX stock plunged by -3.42% ($0.77) at the time of writing. ONTX stock closed Thursday’s session at $0.80 gaining 21.63%. The stock
In the premarket, ONTX stock plunged by -3.42% ($0.77) at the time of writing. ONTX stock closed Thursday’s session at $0.80 gaining 21.63%. The stock
Onconova Therapeutics Inc. (ONTX) is going up in the pre-market on March 18, 2021, as of this writing. The stock went up 14.95% yesterday as
ONTX shares have skyrocketed over 250% so far this year. What’s coming up next? Shares of Onconova Therapeutics (ONTX) have been on a skywalk. The biopharmaceutical
It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention. The
Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most
BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc.
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biotechnology corporation dedicated to the research and production of innovative cancer therapy drugs surged over 31% at $0.38 in
Onconova Therapeutics Inc [NASDAQ:ONTX] is one of the most interesting stocks to watch today. This follows the company’s announcement that it has initiated a phase
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.